BAX602

· Baxter Healthcare Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BAX602, covering 2024-07-22 to 2024-07-22. Get the full timeline:

Most recent: Clinical Trial Update: BAX602 in Preventing the Adhesion Around Great Cardiac Vessels in Pediatric Patients With Congenital Heart Disease Undergoing Re-do Open Heart Surgery (Japan Trial) [NA]

See pricing